INNOVIVA, INC. (INVA) Share buybacks
- Total buybacks · last 12 months (USD): Value $55.85M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $55.85M | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 55.85M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $55.85M | (m) | (m) |
| 2026-03-31 | $24.78M | (m) | (m) |
| 2025-12-31 | $4.53M | (m) | (m) |
| 2025-09-30 | $0.00 | (m) | (m) |
| 2025-06-30 | $0.00 | (m) | (m) |
| 2025-03-31 | $5.21M | (m) | (m) |
| 2024-12-31 | $14.78M | (m) | (m) |
| 2024-09-30 | $29.41M | (m) | (m) |
| 2024-06-30 | $40.48M | (m) | (m) |
| 2024-03-31 | $44.56M | (m) | (m) |
| 2023-12-31 | $75.73M | (m) | (m) |
| 2023-09-30 | $69.59M | (m) | (m) |
| 2023-06-30 | $58.52M | (m) | (m) |
| 2023-03-31 | $49.24M | (m) | (m) |
| 2022-12-31 | $8.50M | (m) | (m) |
| 2022-09-30 | $0.00 | (m) | (m) |
| 2022-06-30 | $0.00 | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) |
| 2021-12-31 | $394.15M | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) |
| 2019-12-31 | $0.00 | (m) | (m) |
| 2018-12-31 | $0.00 | (m) | (m) |
| 2018-09-30 | $80.00M | (m) | (m) |
| 2017-12-31 | $97.50M | (m) | (m) |
| 2017-09-30 | $30.03M | (m) | (m) |
| 2017-06-30 | $33.76M | (m) | (m) |
| 2017-03-31 | $52.74M | (m) | (m) |
| 2016-12-31 | $78.09M | (m) | (m) |
| 2016-09-30 | $91.20M | (m) | (m) |
| 2016-06-30 | $69.97M | (m) | (m) |
| 2016-03-31 | $50.99M | (m) | (m) |
| 2015-12-31 | $25.64M | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) |
| 2014-12-31 | $0.00 | (m) | (m) |
| 2013-12-31 | $0.00 | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |